THINK Surgical Secures up to $65 Million of Growth Capital

THINK Surgical Secures up to $65 Million of Growth Capital

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

THINK Surgical, Inc., a leading innovator of orthopedic surgical robots, announced it has entered into a debt facility with Symbiotic Capital to provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital. The proceeds will be used by THINK to continue to advance its dual channel commercial strategy for its TMINI® Miniature Robotic System.

WilmerHale advised THINK in the transaction.

The WilmerHale team was led by Glenn Pollner, Brandt Tierney, and Avery Reaves, and included Michael Katz, Jordana Tonkiss, Jamie Wolf, and Ariana Raitano, with additional assistance from Meghan Walsh, Amanda Albert, Jeff Johnson, Andrew Walsh, Katelyn Schwartz, and Louise Luongo.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel